Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 13, 2016British Journal of HaematologyOpen Access

Multicentre, randomised phaseIIIstudy of the efficacy and safety of eltrombopag in Chinese patients with chronic immune thrombocytopenia

View Full Paper
Ask AI
Bookmark
Share

Authors

RYRenchi YangJLJunmin LiJJJie Jin

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Yang et al. (2016) studied this question.

synapsesocial.com/papers/6a82e6fc57df60cfb510c671https://doi.org/10.1111/bjh.14380
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia: results of the long-term, open-label EXTEND study2012 · 338 citations
  2. 2The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia2011 · 1,869 citations
  3. 3Current management of immune thrombocytopenia2013 · 89 citations
  4. 4Splenectomy for Chronic Idiopathic Thrombocytopenic Purpura in Children: A Single Center Study in China2006 · 31 citations